Search Results for: GLOBAL DELIVERY MARKET Advanced Drug
Articles
GLOBAL DELIVERY MARKET - Advanced Drug Delivery Systems: mAb, RNAi, & Breaking the Blood-Brain Barrier November 19, 2014
Kevin James, Shalini Dewan, MS, Kim Lawson, and Usha Nagavarapu believe advances in understanding human biology and diseases are opening new and exciting possibilities in the biotechnology industry. R&D spending, along with increasing competition, patent expiries, and new and emerging technologies will continue to shape growth in this market for the foreseeable future.
New Report on Global Markets for Advanced Drug Delivery Systems January 7, 2014
According to a new technical market research report, Global Markets and Technologies for Advanced Drug Delivery Systems, from BCC Research...Bespak Confirms Inhaled & Nasal Drug Delivery Business Separation From Recipharm April 2, 2024
Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site….
SPECIAL FEATURE - Excipients: Advanced Biologics Require Innovative Excipient Science March 29, 2024
Contributor Cindy H. Dubin speaks with several leading companies to discuss novel and functional excipients being developed, the role they will play in reformulations and new formulations, and their versatility in drug delivery.
Noramco Announces Strategic Alignment With Purisys & Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API & Drug Product Supply Chain Services Provider March 14, 2024
Noramco recently announced its launch of the Noramco Group, a newly created comprehensive North American-based supply chain solution including subsidiaries Purisys, Noramco, and the newly acquired….
DRUG DISCOVERY - Benefits of Acoustic Liquid Handling in Drug Discovery February 29, 2024
John Fuller, PhD, believes automated acoustic liquid dispensing technology is a game changer – whether deployed as a stand-alone instrument, in a scaled-up workstation, or as part of fully integrated systems – when it comes to handling complexity in efficient and cost-effective ways.
BioCina & NovaCina Forge Strategic Alliance to Offer Biologics Developers Integrated Drug Substance & Drug Product Solutions February 28, 2024
BioCina Pty Ltd. and NovaCina Pty Ltd. recently announced a strategic partnership to provide integrated drug substance and drug product solutions for….
Evonik Partners With University of Mainz to Commercialize New Class of PEG Lipids for Nucleic Acid Delivery February 20, 2024
Evonik and the University of Mainz have signed a license agreement to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs. Evonik intends to use….
SPECIAL ROUNDTABLE - Leadership Panel: 4 Trends That Will Have the Most Impact on Drug Development in 2024 January 26, 2024
Contributor Cindy H. Dubin asked some of today’s life science leaders what they expect will have the greatest impact on drug development in 2024 and beyond.
SUPPLY CHAIN VISIBILITY - New Tracking Technologies Driving Improvements to Reduce Drug Shortages, Expedite Recalls, Protect & Inform Patients January 26, 2024
Tracy Nasarenko says new technologies are being leveraged along with industry standards to enable full visibility across the entire supply chain, tracking products all the way from manufacturer to end user.
Recipharm Announces Collaboration With Oz-UK to Accelerate the Development of Low Global Warming Potential pMDIs Utilizing HFA-152a Propellant December 5, 2023
Recipharm recently announced a collaboration with Oz-UK to accelerate the development and manufacture of “green” pressurized metered dose inhalers (pMDIs)....Lisata Therapeutics Announces EMA Has Granted LSTA1 Orphan Drug Designation for the Treatment of Pancreatic Cancer October 17, 2023
Lisata Therapeutics, Inc. recently announced the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted orphan drug designation...Recipharm & Honeywell to Speed Development of Inhalers With Near-Zero Global Warming Potential Propellant August 17, 2023
Partnership will reduce environmental footprint of pressurized metered dose inhalers and accelerate transition to lower greenhouse gas respiratory care….
Lisata Therapeutics Announces US FDA Orphan Drug Designation Granted for the Treatment of Malignant Glioma August 8, 2023
Lisata Therapeutics, Inc. recently announced the US FDA has granted Orphan Drug Designation to LSTA1, the company’s lead product candidate,...Ardena & RiboPro Forge Strategic Alliance to Support the RNA Revolution With End-to-End Manufacturing of Advanced mRNA & LNP Solutions July 5, 2023
Leading contract development manufacturer of nanomedicines, Ardena, has joined forces with mRNA and LNP technology specialists RiboPro to form a new...Needle-Free Vaccine Delivery Platform Aims to End Frozen Storage Needs & Improve Access June 6, 2023
aVaxziPen’s innovative vaccine delivery platform aims to improve access to vaccines by removing the need for frozen storage and enabling easier distribution and deployment….
First on the Market: Safely Storing Deep-Cold Medications With Prefillable Polymer Syringes From SCHOTT Pharma May 17, 2023
SCHOTT Pharma’s prefillable polymer syringes are a trailblazing solution for drug applications that need to be stored and transported on dry ice at temperatures approaching -100°C…..
Empty Capsules Market is Expected to Reach $4.9 Billion May 15, 2023
The empty capsules industry is poised for significant growth in the near future. With the rising demand for pharmaceutical and...SPECIAL FEATURE - Parenteral Drug Delivery: Could a Dose of AI Improve Development? May 1, 2023
Contributor Cindy H. Dubin speaks with several innovative companies to highlight the strides they are currently making toward improving dose accuracy, integrating design safety, and accelerating time to market.
MARKET TRENDS - Emerging Trends in Injectable Drug Formulation & Delivery March 1, 2023
Martin Gonzalez, PhD, details current trends in sterile injectable formulations and delivery devices and highlights the challenges pharma and its CDMO partners are facing bringing emerging parenteral breakthroughs to patients.
